Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy!
- 11 August 2005
- journal article
- review article
- Published by Elsevier BV in Acta Tropica
- Vol. 95 (3), 305-315
- https://doi.org/10.1016/j.actatropica.2005.06.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparumActa Tropica, 2005
- PiperaquineDrugs, 2005
- Plasmodium falciparummalaria disease manifestations in humans and transmission toAnopheles gambiae: a field study in Western KenyaParasitology, 2004
- Adherence to the combination of sulphadoxine–pyrimethamine and artesunate in the Maheba refugee settlement, ZambiaTropical Medicine & International Health, 2004
- WHO, the Global Fund, and medical malpractice in malaria treatmentThe Lancet, 2004
- Artesunate combinations for treatment of malaria: meta-analysisThe Lancet, 2004
- Dapsone Therapy for Malaria During PregnancyDrug Safety, 2004
- Efficacy and Safety of Dihydroartemisinin‐Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum MalariaClinical Infectious Diseases, 2002
- A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian childrenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malariaBritish Journal of Clinical Pharmacology, 1996